ArticleScientific reports2025
Curcumin reduces pain after spinal cord injury in rats by decreasing oxidative stress and increasing GABAA receptor and GAD65 levels.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Dose and parameter specific effects of curcumin on neuropathic pain, cavity formation, and non-coding RNA expression in a spinal cord injury model.Scientific reports · 2026Article
- Curcumin as an Antioxidant Against Ziprasidone Induced Lipid Peroxidation in Human Plasma: Potential Relevance to Cortico Subcortical Circuit Function.International journal of molecular sciences · 2025Article
- Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS).International journal of molecular sciences · 2025Review
- An injectable curcumin-loaded hydrogel for neuroprotective treatment promote nerve tissue repair in rat severe spinal cord injury.Frontiers in bioengineering and biotechnology · 2025Article
- Plants, Pills, and the Brain: Exploring Phytochemicals and Neurological Medicines.International journal of plant, animal and environmental sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
About 70% of spinal cord injury (SCI) patients experience neuropathic pain (NP), posing an important medical challenge. Painkillers are used to manage pain today and often have undesirable side effects. Curcumin's antioxidant properties may help alleviate NP following SCI (NP-SCI). We decided to study curcumin's effects on NP-SCI for the first time. Male Wistar rats were divided into five groups (n = 8): Control (no injury/no treatment), Sham (laminectomy), SCI (spinal cord compression at T11-T12 using a clip), Curcumin100 and Curcumin200 (Curcumin at 100 and 200 mg/kg administered 30 min after SCI for 10days). Motor function, allodynia, and hyperalgesia were assessed using the BBB scale, acetone, and tail-flick until six weeks after SCI. H&E staining for assaying cavity, western blot for measuring GAD65 and GABA-A receptors, and biochemical kits for assaying SOD, catalase, total antioxidant capacity, and MDA were used. PRISM software analyzed data. Results showed significant improvements in motion, allodynia, hyperalgesia, cavity, urinary retention (P < 0.0001), and weight in curcumin treatments. There was also a reduction in MDA, with increasing GABA-A receptors, GAD65, and antioxidants in them. Findings suggest curcumin may provide good analgesic effects through its antioxidants, and extensive studies are needed to confirm it as a treatment for NP-SCI in the clinic. Keyboards: spinal cord injury, curcumin, antioxidant, pain, GABA, GAD65 enzyme.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.